ARTICLE | Company News
Apricus Biosciences, BioTox Sciences deal
July 11, 2011 7:00 AM UTC
Apricus (formerly known as NexMed Inc.) sold its Bio-Quant Inc. subsidiary to CRO BioTox for $5 million, plus up to $20 million over 10 years based on BioTox's projected revenues. Bio-Quant is a drug...